OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
Miravant Medical Technologies is asking the FDA to okay a new drug application for marketing approval of its SnET2-PDT as a treatment for patients with wet form of age-related macular degeneration (AMD).